Hematologic Maligancy Conference - Jan.16, 2013

Milwaukee, WI US
January 16, 2013

This educational activity is based on case presentations and subsequent small group discussions of patients with hematologic malignancies that are being evaluated, treated and followed in the Department of Hematology and Oncology, and that have diagnostic or follow-up material evaluated in the Division of Hematopathology.  The goal of this multimodality approach is to insure that the best patient care is being delivered by both Hematologists/Oncologists and Pathologists.

This educational activity is designed to:
Improve competence, so that Hematologists/Oncologists will be able to appropriately order expensive ancillary diagnostic tests; Hematologists/Oncologists will be able to recognize the salient morphologic, immunophenotypic, cytogenetic, and molecular features of common hematologic malignancies; Hematologists/Oncologists will know the diagnostic and prognostic characteristics of the disease entities described in the current WHO classification of leukemias and lymphomas; Hematopathologists will be familiar with emergent therapeutic options and clinical trials available and how they apply to patients diagnosed in our service; Hematopathologists will be constantly updated with the clinical practices of the Department of Hematology and Oncology, in order to continue to improve and provide optimal patient care. 

The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
 
The Medical College of Wisconsin designates this Live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Hours of  Participation for Allied Health Professionals
The Medical College of Wisconsin designates this activity for up to 1.0 hours of participation for continuing education for allied health professionals.

Target Audience

Pathologists

Learning Objectives

Learning objective were identified for both Hematologists/Oncologists and Hematopathologists.
For Hematologists/Oncologists:  By completing this activity, I will be able to:

  1. To improve my ability to appropriately order expensive ancillary diagnostic tests. 
  2. To improve and maintain my ability to recognize the salient morphologic, immunophenotypic, cytogenetic, and molecular features of common hematologic malignancies.
  3. For Hematopathologists:  By completing this activity, I will be able to:
  4. To maintain and update my knowledge of emergent therapeutic options and availability of clinical trials, and how they apply to patients diagnosed in our service.
  5. To constantly update myself with the clinical practices of the Department of Hematology and Oncology, in order to continue to improve outcomes and provide optimal patient care. 
     
Additional information

CME Coordinator Contact Information

Name: 
Linda Caples
Phone Number: 
+1 (414) 955-4900
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.
Course opens: 
01/09/2013
Course expires: 
01/16/2013
Event starts: 
01/16/2013 - 8:00am
Event ends: 
01/16/2013 - 9:00am
Cost:
$0.00
DynaCare Building
9200 W. Wisconsin Ave
someroom
Milwaukee, WI 53226
United States

H.O. MD

No relevant financial relationships to disclose

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™
    AMA PRA Category 1 Credit(s)™
  • 1.00 Hours of Participation
    Hours of Participation credit.

Accreditation Period

Course opens: 
01/09/2013
Course expires: 
01/16/2013

Price

Cost:
$0.00
Please login or register to take this course.